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Abstract 
The Great East Japan Earthquake, which occurred on March 11, 2011, and its subsequent Fukushima 
Daiichi Nuclear Power Plant accident, prompted implementation of the Thyroid Ultrasound Exami-
nation (TUE) program as a part of the Fukushima Health Management Survey. The purpose of this 
program is to support residents of Fukushima Prefecture, and to analyze the health effects of the re-
leased radionuclides. Regardless of relatively high participation rates and a well-planned diagnostic 
flow, it is conceivable that not all thyroid cancer cases can be detected by the TUE program. The 
aims of the present study were to identify and characterize these “outside” cases, targeting patients 
at Fukushima Medical University (FMU) Hospital. As of June 30, 2017, we have successfully iden-
tified 11 outside cases. These corresponded to 5.7% of the 194 subjects who were identified as 
having thyroid cancer or suspected thyroid cancer in the TUE program. Although the outside sub-
jects of other institutes were not investigated, the present study may have identified the majority of 
outside subjects in Japan, considering that FMU Hospital treats a large number of thyroid cancer 
subjects. Furthermore, the characteristics of the 11 subjects were not different from those of the 
subjects identified in the TUE program. These findings confirm that the TUE program was able to 
identify subjects of thyroid cancer adequately and sufficiently.
Key words : thyroid cancer, thyroid ultrasound examination, Fukushima Health Management Sur-
vey, Fukushima Daiichi Nuclear Power Plant accident.
Introduction
Following the Great East Japan Earthquake and 
the resulting devastating tsunami on March 11, 
2011, the Fukushima Daiichi Nuclear Power Plant 
accident occurred, releasing a large amount of radio-
nuclides, including 131I, into the environment. An 
increase in childhood thyroid cancer was of great 
concern among the residents of Fukushima Prefec-
ture, because more than 6,000 children with thyroid 
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cancer had been reported after the Chernobyl nucle-
ar accident in 19861). The Thyroid Ultrasound Ex-
amination (TUE) program, therefore, was imple-
mented on a voluntary basis as a part of the 
Fukushima Health Management Survey (FHMS), 
which was being conducted to support the residents 
of Fukushima Prefecture and analyze the health ef-
fects of radiation2). The TUE program targeted ap-
proximately 380,000 Fukushima Prefectural resi-
dents who were either aged 18 years or younger at 
the end of March 2011, or who were born in the fol-
lowing fiscal year, starting in April 2011. The first-
round examination, also known as the Preliminary 
Baseline Survey, was started in October 2011 to ob-
tain baseline data. The second-round examination, 
called the first Full-scale Survey (FSS), and the 
third-round examination, called the second FSS, 
were conducted in April 2014 and April 2016, re-
spectively. An FSS was then to be conducted every 
two years thereafter. 
In each round, thyroid ultrasonography was 
used in the primary examination as a screening tool 
for thyroid cancer. Subjects who did not have nod-
ules or cysts, and those who had nodules ≤5.0 mm 
and/or cysts ≤20.0 mm were categorized as A cate-
gory, and were recommended to receive a primary 
examination in the following round. Those who 
had nodules >5.0 mm or cysts >20.0 mm, which ac-
counted for approximately 0.7-0.8% of all examin-
ees, were categorized as either B or C. B category, 
which accounted for most of these cases, was for 
those who did not require urgent medical examina-
tion. Those requiring urgent medical examination 
were categorized as C. Subjects in the B and C 
categories were recommended to proceed to a con-
firmatory examination, which consisted of a second 
ultrasound examination, blood and urine tests, and, 
if indicated, fine needle aspiration cytology (FNAC) 
as previously reported in detail3,4). At the comple-
tion of the second round, no relationship was as-
sumed between the estimated total thyroid radiation 
dose and occurrence of the thyroid cancer5).
Regardless of the relatively high participation 
rates, i.e., 81.7% for the first round and 71.0% for 
the second6,7), and the well-planned diagnostic 
flow3,4), it is inevitable that not all thyroid cancer or 
suspected cancer cases can be detected by any kind 
of screening program, including the TUE program. 
As such cases are outside the list of subjects with 
thyroid cancer or suspected thyroid cancer found in 
the TUE program, and are not utilized for analyses 
of thyroid cancer occurrence, in the current manu-
script the authors have named them “outside” cas-
es. The present study was undertaken to identify 
and characterize these outside cases, targeting pa-
tients at FMU Hospital. 
Subjects and Methods
Among the target subjects of the TUE program, 
we enrolled those who had been diagnosed as having 
thyroid cancer or suspected thyroid cancer by FNAC 
and/or histological examination after surgery in Fu-
kushima Medical University (FMU) Hospital by June 
30, 2017, but had not been detected by the TUE pro-
gram. In order to determine which subjects met 
these criteria, the first step was for both the Depart-
ment of Thyroid and Endocrinology and the Depart-
ment of Clinical Pathology at FMU Hospital to inde-
pendently submit lists of candidates. The former 
department listed all patients born between April 2, 
1992 and April 1, 2012 who had received surgical 
treatment for thyroid cancer or suspected thyroid 
cancer between October 9, 2011 and June 30, 2017. 
The latter department listed patients in the same 
age range who were diagnosed as having malignancy 
or suspicious of malignancy via FNAC and/or were 
diagnosed as having thyroid carcinoma by histologi-
cal examination of surgical specimens. Patients 
who were assumed to be living in prefectures other 
than Fukushima Prefecture at the time of the acci-
dent were excluded. The lists from both depart-
ments were combined to eliminate overlap of names 
and other identifiers. 
The next step was to send the combined list to 
the Radiation Medical Science Center, which is in 
charge of the FHMS, and investigate whether each 
listed subject was recorded as a case of malignancy 
or suspected malignancy by the TUE program. In 
cases where the subject was a target resident of the 
TUE program, but was not listed as having malig-
nancy or suspected malignancy, he or she was cate-
gorized as an outside subject. The following infor-
mation for each outside subject was obtained for 
detailed analysis from the Radiation Medical Science 
Center :  area of residence at the time of the acci-
dent, and the subject’s own history of participation 
in the TUE program, if any.
Written informed consent, including the use of 
collected information for research purposes, was ob-
tained from each subject and/or their guard-
ian. This research was approved by the Ethics 
Committee of FMU (no. 29221), which is guided by 
local policy, national law, and the World Medical As-
sociation Declaration of Helsinki. The results of 
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the present study were partly presented at the 10th 
Thyroid Ultrasound Examination Evaluation Sub-
committee, held on July 18, 2018.
Results
The lists of surgical cases submitted by the two 
departments, i.e., the Department of Thyroid and 
Endocrinology and the Department of Clinical Pa-
thology at FMU Hospital, matched exactly, and 160 
surgically treated cases as of June 30, 2017 were 
identified. The latter department also presented a 
list of 20 subjects having received FNAC, which had 
been carried out at FMU Hospital in a clinical set-
ting different from the TUE program. Among the 
20 subjects, seven were diagnosed as having malig-
nancy and one was diagnosed as having suspected 
malignancy ; all eight of these subjects belonged to 
the 160 surgically treated cases. There were no 
subjects who had been diagnosed as having malig-
nancy or suspected malignancy by FNAC, but had 
not undergone surgery. The remaining 12 subjects 
were diagnosed as having findings of “undetermined 
significance” by FNAC according to the Japanese 
Society of Thyroid Surgery8), which corresponds to 
“Atypia of Undetermined Significance / Follicular Le-
sion of Undetermined Significance (AUS / FLUS)” 
according to the Bethesda system9). One among 
these 12 subjects received surgery and was counted 
among the 160 surgically treated subjects. These 
findings indicate that all subjects who had received 
surgery for thyroid cancer or suspected thyroid can-
cer in FMU Hospital were listed and, in addition, all 
subjects diagnosed as such by FNAC were success-
fully identified and included among the 160 surgical-
ly treated cases in the present study. 
Among the 160 surgically treated subjects, 148 
were counted as having thyroid cancer or suspected 
thyroid cancer by the TUE program. The remain-
ing 12 subjects, therefore, were considered to be 
possible outside cases.
The histological diagnoses in 11 of these 12 
subjects consisted of thyroid cancer ; the remaining 
case was deemed benign. FNAC, which had been 
performed at FMU Hospital in six subjects and in 
other institutions in the remaining six, resulted in 
diagnosis of malignancy or suspected malignancy in 
11 subjects, and follicular neoplasm in one. The 
subject with follicular neoplasm underwent endo-
scopic surgery, and the diagnosis was histologically 
confirmed as follicular adenoma. This subject was 
not classified as an outside case, not only because 
the final diagnosis was histologically benign, but also 
because FNAC disclosed the diagnosis of follicular 
neoplasm ;  this is in contrast to the TUE program, 
where subjects are only classified as having malig-
nancy or suspected malignancy by FNAC. Thus, 
the 11 cases diagnosed by FNAC that were then 
confirmed histologically were considered to be the 
outside cases. 
How these 11 outside subjects were eventually 
diagnosed in relation to their participation in the TUE 
program was investigated (Table 1). One subject 
had not participated in the program at all, but was re-
ferred to FMU Hospital because of incidental ultra-
sound detection of a thyroid nodule by a family physi-
cian (a). The remaining ten subjects had joined the 
program at least once, with final participation in the 
first round for three subjects and in the second round 
for seven. Among the ten subjects, two were judged 
Table 1. Routes by which thyroid cancer diagnoses were made on the 11 outside subjects
Routes to diagnosis Number of subjects
a Referral to FMU Hospital by other institutes, with no participation in the TUE pro-gram or after A categorization in primary examination of the TUE program. 3 3
a
b B category at primary examination, no consultation with confirmatory examination, but direct referral to FMU Hospital by another institute. 1
8bc B category at primary examination 
and consultation with confirmatory 
examination.
Transfer to health insurance-based sys-
temc without FNAC because of not meet-
ing the indication criteria.
5
7
d
Transfer to health insurance-based sys-
temc after diagnosis of undetermined sig-
nificance by FNAC.
2
a Diagnosis of thyroid cancer was not triggered by the TUE program.
b Diagnosis of thyroid cancer was triggered by the TUE program
c Transfer from the confirmatory examination of the TUE program to the health insurance-based system 
(separate from the TUE program) was selected, because further periodic and close observation for possible 
diagnosis of thyroid cancer was considered preferable to waiting for the next round of the TUE program.
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as A category in the primary examination, which does 
not necessitate a confirmatory examination, but were 
later referred to FMU Hospital from other institutions 
for consultation of thyroid nodules (a). Their thyroid 
abnormalities had been detected by a private thyroid 
screening test in one subject and found by an ultra-
sound test by a physician during an incidental consul-
tation in the other subject. The remaining eight 
subjects were categorized as B in the primary exami-
nation, which necessitates confirmatory examination 
(b-d). One subject, however, did not receive confir-
matory examination and was eventually referred to 
FMU Hospital three years later from another medi-
cal institute because of suspected malignancy by 
FNAC (b). The other seven subjects proceeded to 
undergo the confirmatory examination (c, d). Five 
subjects among the seven did not receive FNAC, be-
cause they did not meet the indication criteria for 
FNAC (c) ;  the other two received FNAC and were 
diagnosed as having findings of undetermined signif-
icance (d). All seven subjects were then trans-
ferred to a public health insurance-based system be-
cause of the necessity for further periodic and close 
observation for possible diagnosis of thyroid can-
cer. This kind of observation is essential for such 
individuals, and cannot be achieved if they have to 
wait for the following examination in the TUE pro-
gram. The average duration between the first visit 
to insurance-based medical practice and surgical 
treatment in these seven subjects was 613±534 
days (median : 565 days, range : 400-1,184 days). 
The characteristics of the 11 outside subjects 
were investigated, and are included in Table 2. 
There were four males and seven females, and the 
average ages were 13.8±4.0 years at the time of the 
accident and 18.3±3.8 years at the time of sur-
gery. The numbers of subjects aged 0-4, 5-9, 10-
14, 15-19, and 20-25 years at the time of the acci-
dent were one, one, four, five and zero, respectively, 
and the numbers of subjects in the same age groups 
at the time of surgery were zero, one, zero, six and 
four, respectively. Regarding area of residence at 
the time of the accident, four subjects were living 
somewhere in the 13 municipalities of the nationally 
designated evacuation zones, four were living in the 
Nakadori area (the central part of Fukushima Prefec-
ture), three were living in the Hamadori area (the 
eastern part), and none were in the Aizu area (the 
western part). The tumor size was defined as the 
larger of two diameters, both measured at the tu-
mor’s widest point ; one measured by ultrasonogra-
phy performed immediately before surgery, and the 
other physically measured after the tumor had been 
excised, was 14.0±5.1 mm (6.3-24.6 mm) on aver-
age. The histological diagnoses were papillary thy-
roid carcinoma in all cases (classic type in nine, fol-
licular type in one, and solid sclerosing type in one). 
Discussion
The present study was undertaken to identify 
and characterize the outside subjects of the TUE 
program, targeting patients at FMU Hospital. Sur-
gically treated cases were fully detected utilizing a 
combination of lists submitted by two departments, 
which included eight subjects who had been diag-
nosed as having malignancy or suspected malignan-
cy by FNAC performed at FMU Hospital, implying 
Table 2.  Characteristics of the 11 outside subjects in comparison with those of the subjects identified in the 
TUE program6,7,10)
Subjects outside  the TUE 
program
Subjects identified in the TUE program (first 
round6, second round7, and third round, as of June 
30, 201710)
1. Total number 11 194
2. Male : female 4 : 7 75 : 119
3. Age at the accident 13.8±4.0 years 14.9±2.6, 12.6±3.2 and 10.6±1.6 years
4. Age (at diagnosis or sur-
gery)
18.3±3.8 years
 (at surgery)
17.3±2.7, 16.9±3.2 and 16.1±1.8 years
 (at diagnosis)
5. Area of residence at the 
accidenta
4 : 4 : 3 : 0 34 : 108 : 34 : 17 (total of 193 casesb)
6. Tumor size 14.0±5.1 mm 13.9±7.8, 11.1±5.6 and 12.1±3.1 mm
7. Histological diagnosis af-
ter surgery
11 papillary thyroid carci-
nomas
152 papillary thyroid carcinomas, one poorly dif-
ferentiated thyroid carcinoma, one benign tumor, 
one other thyroid carcinoma
a Area of residence was categorized as :  the 13 evacuation municipalities, the Nakadori area, the Hamadori area, 
and the Aizu area.
b One histologically diagnosed benign case was excluded.
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that all pertinent subjects were recruited. The 
TUE program ends with the diagnosis of malignancy 
or suspected malignancy in each subject, and the 
clinical information thereafter is not covered by the 
protocol of the program. The current study was 
conducted at FMU Hospital, which provides health 
insurance-based services, in cooperation with the 
Radiation Medical Science Center responsible for 
the FHMS after approval by the ethics committee of 
FMU.
The present study revealed that the number of 
outside subjects seen at FMU Hospital was 11 as of 
June 30, 2017. Since the TUE program had identi-
fied 194 subjects with thyroid cancer and suspected 
thyroid cancer by that same date6,7,10), the outside 
subjects accounted for 5.7%, indicating that the ma-
jority of subjects with thyroid cancer had been de-
tected by the TUE program. The characterization 
of the outside subjects is also important, because 
some subjects with particular characteristics might 
be predominantly detected or undetected by the 
TUE program. The characteristics of the outside 
subjects are summarized in comparison with those 
of the subjects identified in the TUE program in Ta-
ble 2. Gender ratios, ages and tumor sizes were 
similar. Area of residence at the time of the acci-
dent could not be meaningfully compared because of 
the small numbers of cases. Histological diagnoses 
in both series were papillary thyroid carcinoma in 
most cases, with only a few exceptions. Thus, it is 
unlikely that these outside subjects, if taken into 
consideration, would affect the whole picture of thy-
roid cancer in the younger generations of Fukushima 
Prefecture. 
In the current study, how the malignancies and 
suspected malignancies of the outside subjects went 
undetected by the TUE program was also investi-
gated (Table 1).  It is not surprising that : some 
residents did not participate in the program (a) ; 
some were diagnosed during the intervals between 
the rounds (a) ;  and some, having been categorized 
as B in the primary examination, were diagnosed by 
FNAC in a medical institute but not through the con-
firmatory examination of the TUE program (b). 
While these irregular cases do exist, it was also 
shown that such instances were rare. More discus-
sion may be needed on the seven subjects who had 
been evaluated in the confirmatory examinations, 
but were transferred to the health insurance-based 
system, and were eventually diagnosed. One may 
argue that further prolongation of the confirmatory 
examination itself will effectively diminish the num-
ber of outside subjects. The necessary period for 
such observation, however, seems too long, as 
shown in the present study ;  the average duration 
between the first visit to a medical practice and sur-
gical treatment in these seven subjects was 
613±534 days. Since a period of 15 months after 
completion of the primary examinations was needed 
to obtain the fixed data of each of the first and sec-
ond rounds6,7), further delay would seriously disturb 
any timely analyses. Repeated and long-standing 
confirmatory examination would also be a great bur-
den in practicing the TUE program. Therefore, it 
may be practical to prolong confirmatory examina-
tions only in cases where diagnosis can be reached 
in a relatively short time. 
There are two limitations in the present study. 
Firstly, the outside subjects enrolled were from 
FMU Hospital only. One may point out that there 
should also be a considerable number of outside sub-
jects from other institutes. The actual number of 
such cases could not be determined by the current 
study alone. However, we do not believe that it 
would be a large number considering that : (1) 
among the total of 187 subjects who had been diag-
nosed as having malignancy or suspected malignan-
cy in the first and second rounds, only nine subjects 
(4.8%) were identified in the confirmatory examina-
tion performed in prefectures other than Fukushi-
ma ; and (2) among the 132 subjects who underwent 
surgery for thyroid cancer as of March 2016, only 
seven (5.3%) underwent surgery in institutes other 
than FMU Hospital11). Therefore, it seems likely 
that the majority of outside subjects diagnosed 
across Japan were detected in the present study. 
Secondly, the present study was undertaken as of 
June 30, 2017, and the results of a similar study con-
ducted in the future may be different. The number 
of outside cases may increase as participation rates 
decrease and examinations performed outside Fuku-
shima Prefecture increase. To accurately identify 
all subjects with thyroid cancer in the future, utiliza-
tion of national and regional cancer registries will 
probably become a more potent method5).
In conclusion, the present study successfully 
identified 11 outside subjects with thyroid cancer or 
suspected thyroid cancer, seen at FMU Hospital as 
of June 30, 2017. These accounted for 5.7% of the 
194 subjects whom the TUE program had identi-
fied. Although outside subjects from other insti-
tutes were not investigated, the present study 
seemed to cover a major part of the outside subjects 
in Japan overall. These findings confirm that the 
cases of malignancy and suspected malignancy de-
tected by the TUE program were accurate and their 
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data were sufficient for various kinds of analyses.
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